Erisyon is commercializing the world’s first single molecule protein sequencer that promises to transform the way they detect, treat, and track disease. Inheriting over a decade of work performed at the University of Texas at Austin's Center for Systems and Synthetic Biology, Erisyon was founded in March 2018 by a group of technologists and